Increased extracellular pressure enhances cancer cell integrin-binding affinity through phosphorylation of β1-integrin at threonine 788/789

American Journal of Physiology - Cell Physiology

Volumn 296, Issue 1, 2009, Pages

  Craig, David H ^a   Gayer, Christopher P ^a   Schaubert, Keri L ^b   Wei, Yanzhang ^c,d   Li, Jinhua ^c   Laouar, Yasmina ^b   Basson, Marc D ^a,e  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c GREENVILLE HOSPITAL SYSTEM   (United States)

^d CLEMSON UNIVERSITY   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Adhesion; Mechanotransduction; Metastasis

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; BETA1 INTEGRIN; FIBRONECTIN; THREONINE;

ARTICLE; BINDING AFFINITY; CANCER CELL CULTURE; CELL ADHESION; COLON CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN PHOSPHORYLATION; TUMOR CELL; WILD TYPE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ACTININ; ANIMALS; ANTIGENS, CD29; BINDING SITES; CELL ADHESION; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COLONIC NEOPLASMS; COS CELLS; FIBRONECTINS; FOCAL ADHESION KINASE 1; HUMANS; MECHANOTRANSDUCTION, CELLULAR; MICE; MICE, KNOCKOUT; NEOPLASM METASTASIS; OLIGOPEPTIDES; PHOSPHORYLATION; PRESSURE; PROTEIN CONFORMATION; RECOMBINANT FUSION PROTEINS; SRC-FAMILY KINASES; THREONINE; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

MURINAE;

EID: 58349107266     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00355.2008     Document Type: Article

References (75)

1. Barreuther MF, Grabel LB. The role of phosphorylation in modulating beta 1 integrin localization. Exp Cell Res 222: 10-15, 1996.
2. Basson MD, Yu CF, Herden-Kirchoff O, Ellermeier M, Sanders MA, Merrell RC, Sumpio BE. Effects of increased ambient pressure on colon cancer cell adhesion. J Cell Biochem 78: 47-61, 2000.
3. Bazzoni G, Ma L, Blue ML, Hemler ME. Divalent cations and ligands induce conformational changes that are highly divergent among beta1 integrins. J Biol Chem 273: 6670-6678, 1998.
4. Bazzoni G, Shih DT, Buck CA, Hemler ME. Monoclonal antibody 9EG7 defines a novel beta 1 integrin epitope induced by soluble ligand and manganese, but inhibited by calcium. J Biol Chem 270: 25570-25577, 1995.
5. Blaschke F, Stawowy P, Goetze S, Hintz O, Grafe M, Kintscher U, Fleck E, Graf K. Hypoxia activates beta(1)-integrin via ERK 1/2 and p38 MAP kinase in human vascular smooth muscle cells. Biochem Biophys Res Commun 296: 890-896, 2002.
6. Boulter E, Van Obberghen-Schilling E. Integrin-linked kinase and its partners: a modular platform regulating cell-matrix adhesion dynamics and cytoskeletal organization. Eur J Cell Biol 85: 255-263, 2006.
7. Chatila TA, Geha RS, Arnaout MA. Constitutive and stimulus-induced phosphorylation of CD11/CD18 leukocyte adhesion molecules. J Cell Biol 109: 3435-3444, 1989.
8. Chigaev A, Zwartz G, Graves SW, Dwyer DC, Tsuji H, Foutz TD, Edwards BS, Prossnitz ER, Larson RS, Sklar LA. Alpha4beta1 integrin affinity changes govern cell adhesion. J Biol Chem 278: 38174-38182, 2003.
9. Craig DH, Haimovich B, Basson MD. α-Actinin-1 phosphorylation modulates pressure-induced colon cancer cell adhesion through regulation of focal adhesion kinase-Src interaction. Am J Physiol Cell Physiol 293: C1862-C1874, 2007.
10. Craig DH, Owen CR, Conway WC, Walsh MF, Downey C, Basson MD. Colchicine inhibits pressure-induced tumor cell implantation within surgical wounds and enhances tumor-free survival in mice. J Clin Invest 118: 3170-3180, 2008.
11. Craig DH, Schaubert KL, Shiratsuchi H, Kan-Mitchell J, Basson MD. Increased pressure stimulates aberrant dendritic cell maturation. Cell Mol Biol Lett 13: 260-270, 2007.
12. Dahl SC, Grabel LB. Integrin phosphorylation is modulated during the differentiation of F-9 teratocarcinoma stem cells. J Cell Biol 108: 183-190, 1989.
13. Diamond MS, Springer TA. The dynamic regulation of integrin adhesiveness. Curr Biol 4: 506-517, 1994.
14. Dregelid E, Svendsen E. Endothelial cell injury in human saphenous veins after manipulation and tweezer grasping. J Cardiovasc Surg (Torino) 29: 464-469, 1988.
15. Duncan RL, Turner CH. Mechanotransduction and the functional response of bone to mechanical strain. Calcif Tissue Int 57: 344-358, 1995.
16. Emenaker NJ, Basson MD. Short chain fatty acids inhibit human (SW1116) colon cancer cell invasion by reducing urokinase plasminogen activator activity and stimulating TIMP-1 and TIMP-2 activities, rather than via MMP modulation. J Surg Res 76: 41-46, 1998.
17. Eto DS, Jones TA, Sundsbak JL, Mulvey MA. Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli. PLoS Pathog 3: e100, 2007.
18. Fagerholm SC, Hilden TJ, Gahmberg CG. P marks the spot: sitespecific integrin phosphorylation regulates molecular interactions. Trends Biochem Sci 29: 504-512, 2004.
19. Fassler R, Pfaff M, Murphy J, Noegel AA, Johansson S, Timpl R, Albrecht R. Lack of beta 1 integrin gene in embryonic stem cells affects morphology, adhesion, and migration but not integration into the inner cell mass of blastocysts. J Cell Biol 128: 979-988, 1995.
20. Felding-Habermann B, O'Toole TE, Smith JW, Fransvea E, Ruggeri ZM, Ginsberg MH, Hughes PE, Pampori N, Shattil SJ, Saven A, Mueller BM. Integrin activation controls metastasis in human breast cancer. Proc Natl Acad Sci USA 98: 1853-1858, 2001.
21. Fujita S, Kudo N, Akasu T, Moriya Y. Detection of cytokeratin 19 and 20 mRNA in peripheral and mesenteric blood from colorectal cancer patients and their prognosis. Int J Colorectal Dis 16: 141-146, 2001.
22. Guller U, Zajac P, Schnider A, Bosch B, Vorburger S, Zuber M, Spagnoli GC, Oertli D, Maurer R, Metzger U, Harder F, Heberer M, Marti WR. Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer. Ann Surg 236: 768-775, 2002.
23. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 110: 673-687, 2002.
24. Johansson MW, Larsson E, Luning B, Pasquale EB, Ruoslahti E. Altered localization and cytoplasmic domain-binding properties of tyrosine-phosphorylated beta 1 integrin. J Cell Biol 126: 1299-1309, 1994.
25. Katsumi A, Naoe T, Matsushita T, Kaibuchi K, Schwartz MA. Integrin activation and matrix binding mediate cellular responses to mechanical stretch. J Biol Chem 280: 16546-16549, 2005.
26. Kavic SM, Basson MD. Environmental factors of temperature, humidity, serum accumulation, and cell seeding increase colon cancer cell adhesion in vitro, with partial characterization of the serum component responsible for pressure-stimulated adhesion. J Surg Res 98: 89-96, 2001.
27. Kim M, Carman CV, Yang W, Salas A, Springer TA. The primacy of affinity over clustering in regulation of adhesiveness of the integrin (alpha)L(beta)2. J Cell Biol 167: 1241-1253, 2004.
28. Knies Y, Bernd A, Kaufmann R, Bereiter-Hahn J, Kippenberger S. Mechanical stretch induces clustering of beta1-integrins and facilitates adhesion. Exp Dermatol 15: 347-355, 2006.
29. Knoll R, Hoshijima M, Chien K. Cardiac mechanotransduction and implications for heart disease. J Mol Med 81: 750-756, 2003.
30. Koivunen E, Wang B, Ruoslahti E. Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins. Biotechnology 13: 265-270, 1995.
31. Konstandin MH, Sester U, Klemke M, Weschenfelder T, Wabnitz GH, Samstag Y. A novel flow-cytometry-based assay for quantification of affinity and avidity changes of integrins. J Immunol Methods 310: 67-77, 2006.
32. Kucik DF, Dustin ML, Miller JM, Brown EJ. Adhesion-activating phorbol ester increases the mobility of leukocyte integrin LFA-1 in cultured lymphocytes. J Clin Invest 97: 2139-2144, 1996.
33. Kuphal S, Bauer R, Bosserhoff AK. Integrin signaling in malignant melanoma. Cancer Metastasis Rev 24: 195-222, 2005.
34. Lenter M, Uhlig H, Hamann A, Jeno P, Imhof B, Vestweber D. A monoclonal antibody against an activation epitope on mouse integrin chain beta 1 blocks adhesion of lymphocytes to the endothelial integrin alpha 6 beta 1. Proc Natl Acad Sci USA 90: 9051-9055, 1993.
35. Less JR, Posner MC, Boucher Y, Borochovitz D, Wolmark N, Jain RK. Interstitial hypertension in human breast and colorectal tumors. Cancer Res 52: 6371-6374, 1992.
36. Li J, Ji J, Holmes LM, Burgin KE, Barton LB, Yu X, Wagner TE, Wei Y. Fusion protein from RGD peptide and Fc fragment of mouse immunoglobulin G inhibits angiogenesis in tumor. Cancer Gene Ther 11: 363-370, 2004.
37. Madri JA, Pratt BM, Yannariello-Brown J. Matrix-driven cell size change modulates aortic endothelial cell proliferation and sheet migration. Am J Pathol 132: 18-27, 1988.
38. Moore-Olufemi SD, Xue H, Allen SJ, Moore FA, Stewart RH, Laine GA, Cox CS Jr. Effects of primary and secondary intra-abdominal hypertension on mesenteric lymph flow: implications for the abdominal compartment syndrome. Shock 23: 571-575, 2005.
39. Mulrooney J, Foley K, Vineberg S, Barreuther M, Grabel L. Phosphorylation of the beta1 integrin cytoplasmic domain: toward an understanding of function and mechanism. Exp Cell Res 258: 332-341, 2000.
40. Mulrooney JP, Hong T, Grabel LB. Serine 785 phosphorylation of the beta1 cytoplasmic domain modulates beta1A-integrin-dependent functions. J Cell Sci 114: 2525-2533, 2001.
41. Nathan SS, DiResta GR, Casas-Ganem JE, Hoang BH, Sowers R, Yang R, Huvos AG, Gorlick R, Healey JH. Elevated physiologic tumor pressure promotes proliferation and chemosensitivity in human osteosarcoma. Clin Cancer Res 11: 2389-2397, 2005.
42. Ni N, Kevil CG, Bullard DC, Kucik DF. Avidity modulation activates adhesion under flow and requires cooperativity among adhesion receptors. Biophys J 85: 4122-4133, 2003.
43. Nilsson S, Kaniowska D, Brakebusch C, Fassler R, Johansson S. Threonine 788 in integrin subunit beta1 regulates integrin activation. Exp Cell Res 312: 844-853, 2006.
44. Opitz F, Schenke-Layland K, Cohnert TU, Stock UA. Phenotypical plasticity of vascular smooth muscle cells-effect of in vitro and in vivo shear stress for tissue engineering of blood vessels. Tissue Eng 13: 2505-2514, 2007.
45. O'Toole TE, Ylanne J, Culley BM. Regulation of integrin affinity states through an NPXY motif in the beta subunit cytoplasmic domain. J Biol Chem 270: 8553-8558, 1995.
46. Paszek MJ, Zahir N, Johnson KR, Lakins JN, Rozenberg GI, Gefen A, Reinhart-King CA, Margulies SS, Dembo M, Boettiger D, Hammer DA, Weaver VM. Tensional homeostasis and the malignant phenotype. Cancer Cell 8: 241-254, 2005.
47. Plantefaber LC, Hynes RO. Changes in integrin receptors on oncogenically transformed cells. Cell 56: 281-290, 1989.
48. Sadoshima J, Izumo S. The cellular and molecular response of cardiac myocytes to mechanical stress. Annu Rev Physiol 59: 551-571, 1997.
49. Sankoh AJ, Huque MF, Dubey SD. Some comments on frequently used multiple endpoint adjustment methods in clinical trials. Stat Med 16: 2529-2542, 1997.
50. Schaff UY, Yamayoshi I, Tse T, Griffin D, Kibathi L, Simon SI. Calcium flux in neutrophils synchronizes beta2 integrin adhesive and signaling events that guide inflammatory recruitment. Ann Biomed Eng 36: 632-646, 2008.
51. Schwartz MA, Ingber DE. Integrating with integrins. Mol Biol Cell 5: 389-393, 1994.
52. Stevens JM, Jordan PA, Sage T, Gibbins JM. The regulation of integrin-linked kinase in human platelets: evidence for involvement in the regulation of integrin alpha 2 beta 1. J Thromb Haemost 2: 1443-1452, 2004.
53. Stroeken PJ, van Rijthoven EA, Boer E, Geerts D, Roos E. Cytoplasmic domain mutants of beta1 integrin, expressed in beta 1-knockout lymphoma cells, have distinct effects on adhesion, invasion and metastasis. Oncogene 19: 1232-1238, 2000.
54. Su X, Mi J, Yan J, Flevaris P, Lu Y, Liu H, Ruan Z, Wang X, Kieffer N, Chen S, Du X, Xi X. RGT, a synthetic peptide corresponding to the integrin beta 3 cytoplasmic C-terminal sequence, selectively inhibits outside-in signaling in human platelets by disrupting the interaction of integrin alpha IIb beta 3 with Src kinase. Blood 112: 592-602, 2008.
55. Sugarbaker PH. Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol 43, Suppl: S15-S25, 1999.
56. Takagi J, Petre BM, Walz T, Springer TA. Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling. Cell 110: 599-511, 2002.
57. Takagi J, Springer TA. Integrin activation and structural rearrangement. Immunol Rev 186: 141-163, 2002.
58. Thamilselvan V, Basson MD. Pressure activates colon cancer cell adhesion by inside-out focal adhesion complex and actin cytoskeletal signaling. Gastroenterology 126: 8-18, 2004.
59. Thamilselvan V, Basson MD. The role of the cytoskeleton in differentially regulating pressure-mediated effects on malignant colonocyte focal adhesion signaling and cell adhesion. Carcinogenesis 26: 1687-1697, 2005.
60. Thamilselvan V, Craig DH, Basson MD. FAK association with multiple signal proteins mediates pressure-induced colon cancer cell adhesion via a Src-dependent PI3K/Akt pathway. FASEB J 21: 1730-1741, 2007.
61. Thamilselvan V, Patel A, van der Voort van Zyp J, Basson MD. Colon cancer cell adhesion in response to Src kinase activation and actin-cytoskeleton by non-laminar shear stress. J Cell Biochem 92: 361-371, 2004.
62. Umpleby HC, Fermor B, Symes MO, Williamson RC. Viability of exfoliated colorectal carcinoma cells. Br J Surg 71: 659-663, 1984.
63. Valmu L, Gahmberg CG. Treatment with okadaic acid reveals strong threonine phosphorylation of CD18 after activation of CD11/CD18 leukocyte integrins with phorbol esters or CD3 antibodies. J Immunol 155: 1175-1183, 1995.
64. Van der Voort van Zyp J, Conway WC, Thamilselvan V, Polin L, Basson MD. Divalent cations influence colon cancer cell adhesion in a murine transplantable tumor model. Am J Surg 190: 701-707, 2005.
65. Van Kooyk Y, Figdor CG. Avidity regulation of integrins: the driving force in leukocyte adhesion. Curr Opin Cell Biol 12: 542-547, 2000.
66. Van Kooyk Y, van Vliet SJ, Figdor CG. The actin cytoskeleton regulates LFA-1 ligand binding through avidity rather than affinity changes. J Biol Chem 274: 26869-26877, 1999.
67. Van Willigen G, Hers I, Gorter G, Akkerman JW. Exposure of ligand-binding sites on platelet integrin alpha IIB/beta 3 by phosphorylation of the beta 3 subunit. Biochem J 314: 769-779, 1996.
68. Walsh MF, Woo RK, Gomez R, Basson MD. Extracellular pressure stimulates colon cancer cell proliferation via a mechanism requiring PKC and tyrosine kinase signals. Cell Prolif 37: 427-441, 2004.
69. Wang N, Butler JP, Ingber DE. Mechanotransduction across the cell surface and through the cytoskeleton. Science 260: 1124-1127, 1993.
70. Wennerberg K, Fassler R, Warmegard B, Johansson S. Mutational analysis of the potential phosphorylation sites in the cytoplasmic domain of integrin beta1A. Requirement for threonines 788-789 in receptor activation. J Cell Sci 111: 1117-1126, 1998.
71. Wennerberg K, Lohikangas L, Gullberg D, Pfaff M, Johansson S, Fassler R. Beta 1 integrin-dependent and -independent polymerization of fibronectin. J Cell Biol 132: 227-238, 1996.
72. Wu JS, Brasfield EB, Guo LW, Ruiz M, Connett JM, Philpott GW, Jones DB, Fleshman JW. Implantation of colon cancer at trocar sites is increased by low pressure pneumoperitoneum. Surgery 122: 1-7, 1997.
73. Xi X, Bodnar RJ, Li Z, Lam SC, Du X. Critical roles for the COOHterminal NITY and RGT sequences of the integrin beta3 cytoplasmic domain in inside-out and outside-in signaling. J Cell Biol 162: 329-339, 2003.
74. Zhang Z, Vuori K, Wang H, Reed JC, Ruoslahti E. Integrin activation by R-ras. Cell 85: 61-69, 1996.
75. Zhou X, Li J. Macrophage-enriched myristoylated alanine-rich C kinase substrate and its phosphorylation is required for the phorbol ester-stimulated diffusion of beta 2 integrin molecules. J Biol Chem 275: 20217-20222, 2000.